Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positron-Emission Tomography | 21 | 2024 | 6259 | 1.040 |
Why?
|
Radiopharmaceuticals | 12 | 2021 | 2658 | 0.960 |
Why?
|
Monoacylglycerol Lipases | 4 | 2022 | 48 | 0.740 |
Why?
|
Hepatic Stellate Cells | 2 | 2022 | 109 | 0.730 |
Why?
|
Molecular Probes | 2 | 2019 | 316 | 0.730 |
Why?
|
Integrin alphaVbeta3 | 1 | 2020 | 111 | 0.690 |
Why?
|
Liver Cirrhosis | 4 | 2022 | 1864 | 0.640 |
Why?
|
Peptides, Cyclic | 1 | 2020 | 401 | 0.610 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2018 | 161 | 0.550 |
Why?
|
Receptors, AMPA | 3 | 2022 | 331 | 0.480 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.480 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1107 | 0.460 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2022 | 2211 | 0.420 |
Why?
|
Ligands | 10 | 2022 | 3293 | 0.380 |
Why?
|
Enzyme Inhibitors | 5 | 2022 | 3800 | 0.360 |
Why?
|
Azetidines | 2 | 2021 | 142 | 0.340 |
Why?
|
Liver Neoplasms | 2 | 2022 | 4249 | 0.330 |
Why?
|
Intestines | 1 | 2018 | 1923 | 0.330 |
Why?
|
Morpholines | 2 | 2024 | 561 | 0.330 |
Why?
|
Carbon Radioisotopes | 7 | 2021 | 592 | 0.280 |
Why?
|
Pyrimidines | 3 | 2024 | 2933 | 0.260 |
Why?
|
Fluorine Radioisotopes | 4 | 2021 | 448 | 0.250 |
Why?
|
Triazoles | 2 | 2021 | 907 | 0.250 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2020 | 895 | 0.240 |
Why?
|
Parkinson Disease | 3 | 2024 | 2774 | 0.240 |
Why?
|
Drug Design | 2 | 2019 | 1078 | 0.230 |
Why?
|
Radioligand Assay | 2 | 2020 | 379 | 0.220 |
Why?
|
Molecular Imaging | 2 | 2020 | 831 | 0.210 |
Why?
|
Molecular Structure | 6 | 2021 | 1907 | 0.200 |
Why?
|
Endocannabinoids | 1 | 2022 | 116 | 0.200 |
Why?
|
Receptors, Vasopressin | 1 | 2021 | 112 | 0.200 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2022 | 223 | 0.190 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2021 | 197 | 0.190 |
Why?
|
Hepatitis C | 2 | 2022 | 1582 | 0.180 |
Why?
|
Naphthyridines | 1 | 2020 | 118 | 0.180 |
Why?
|
Receptor, Muscarinic M4 | 1 | 2018 | 12 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 295 | 0.170 |
Why?
|
Carbon Isotopes | 1 | 2020 | 468 | 0.170 |
Why?
|
Benzoxazoles | 1 | 2019 | 78 | 0.170 |
Why?
|
Brain | 11 | 2022 | 26343 | 0.170 |
Why?
|
Nitriles | 1 | 2024 | 952 | 0.160 |
Why?
|
Tissue Distribution | 5 | 2020 | 2335 | 0.160 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2020 | 212 | 0.160 |
Why?
|
Muscarinic Agonists | 1 | 2018 | 87 | 0.160 |
Why?
|
Acetamides | 1 | 2020 | 249 | 0.160 |
Why?
|
Calcium Channels | 1 | 2022 | 621 | 0.160 |
Why?
|
Rats | 11 | 2021 | 24265 | 0.160 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 697 | 0.160 |
Why?
|
Iodine | 1 | 2020 | 285 | 0.160 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2022 | 644 | 0.150 |
Why?
|
Pyridazines | 1 | 2018 | 201 | 0.150 |
Why?
|
Animals | 23 | 2024 | 168561 | 0.140 |
Why?
|
Mice | 14 | 2024 | 81045 | 0.140 |
Why?
|
Hepatitis | 1 | 2018 | 227 | 0.140 |
Why?
|
Hepatitis B | 1 | 2022 | 695 | 0.140 |
Why?
|
Hematology | 1 | 2019 | 219 | 0.130 |
Why?
|
Carbon Dioxide | 1 | 2020 | 1141 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2020 | 2505 | 0.130 |
Why?
|
Benzodiazepines | 1 | 2021 | 1101 | 0.130 |
Why?
|
Hepacivirus | 2 | 2022 | 1372 | 0.130 |
Why?
|
Autoradiography | 3 | 2021 | 749 | 0.130 |
Why?
|
Metagenomics | 1 | 2018 | 430 | 0.120 |
Why?
|
Structure-Activity Relationship | 4 | 2021 | 3133 | 0.120 |
Why?
|
Pyrroles | 1 | 2020 | 1143 | 0.120 |
Why?
|
Fibroblast Growth Factors | 1 | 2019 | 879 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1806 | 0.110 |
Why?
|
Liver | 4 | 2022 | 7470 | 0.110 |
Why?
|
Feces | 1 | 2018 | 1394 | 0.100 |
Why?
|
Iron | 1 | 2020 | 1773 | 0.100 |
Why?
|
Liver Diseases | 1 | 2020 | 1252 | 0.100 |
Why?
|
Leucine | 2 | 2024 | 560 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2021 | 10943 | 0.100 |
Why?
|
Virus Replication | 1 | 2019 | 2531 | 0.100 |
Why?
|
Antiviral Agents | 1 | 2023 | 2978 | 0.090 |
Why?
|
Embolization, Therapeutic | 1 | 2020 | 1392 | 0.090 |
Why?
|
Hepatocytes | 3 | 2022 | 1209 | 0.090 |
Why?
|
Liver Function Tests | 2 | 2021 | 528 | 0.090 |
Why?
|
Lipid Peroxidation | 2 | 2020 | 270 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2021 | 2956 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 4 | 2020 | 8300 | 0.080 |
Why?
|
Piperazines | 1 | 2019 | 2488 | 0.080 |
Why?
|
Isotope Labeling | 2 | 2019 | 414 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9410 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2018 | 3038 | 0.070 |
Why?
|
Mammals | 2 | 2022 | 1135 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13256 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 21821 | 0.070 |
Why?
|
Contrast Media | 1 | 2019 | 5295 | 0.070 |
Why?
|
China | 2 | 2023 | 2246 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 14720 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 12071 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 5522 | 0.060 |
Why?
|
MicroRNAs | 1 | 2019 | 3731 | 0.050 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2022 | 26 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19862 | 0.050 |
Why?
|
Binding Sites | 2 | 2021 | 6115 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2022 | 7988 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 149 | 0.050 |
Why?
|
Humans | 14 | 2024 | 742088 | 0.050 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 2020 | 13 | 0.050 |
Why?
|
Cyclohexylamines | 1 | 2020 | 21 | 0.050 |
Why?
|
Haplorhini | 1 | 2021 | 551 | 0.050 |
Why?
|
D-Amino-Acid Oxidase | 1 | 2020 | 27 | 0.050 |
Why?
|
Homeostasis | 2 | 2022 | 3335 | 0.050 |
Why?
|
Male | 11 | 2022 | 349538 | 0.050 |
Why?
|
Mice, Knockout | 3 | 2020 | 14554 | 0.050 |
Why?
|
Phenylenediamines | 1 | 2020 | 90 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2020 | 352 | 0.040 |
Why?
|
Cricetulus | 1 | 2021 | 817 | 0.040 |
Why?
|
Iron, Dietary | 1 | 2020 | 141 | 0.040 |
Why?
|
Yttrium Radioisotopes | 1 | 2020 | 93 | 0.040 |
Why?
|
Spiro Compounds | 1 | 2019 | 76 | 0.040 |
Why?
|
Allosteric Regulation | 1 | 2020 | 408 | 0.040 |
Why?
|
Symporters | 1 | 2022 | 363 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2022 | 808 | 0.040 |
Why?
|
CHO Cells | 1 | 2021 | 1407 | 0.040 |
Why?
|
Iron Overload | 1 | 2020 | 243 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 2022 | 513 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2019 | 378 | 0.040 |
Why?
|
Lipogenesis | 1 | 2019 | 212 | 0.040 |
Why?
|
Protein Phosphatase 2 | 1 | 2019 | 229 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2020 | 327 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2021 | 1902 | 0.040 |
Why?
|
Methylation | 1 | 2020 | 1107 | 0.040 |
Why?
|
Microspheres | 1 | 2020 | 777 | 0.040 |
Why?
|
Sphingosine | 1 | 2019 | 307 | 0.040 |
Why?
|
Interferon Type I | 1 | 2021 | 542 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 314 | 0.040 |
Why?
|
Erythropoiesis | 1 | 2020 | 705 | 0.030 |
Why?
|
Adipose Tissue, Brown | 1 | 2022 | 754 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2019 | 608 | 0.030 |
Why?
|
Erythropoietin | 1 | 2020 | 724 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7317 | 0.030 |
Why?
|
Fever | 1 | 2023 | 1612 | 0.030 |
Why?
|
Female | 10 | 2022 | 379592 | 0.030 |
Why?
|
Spleen | 1 | 2021 | 2359 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2020 | 1159 | 0.030 |
Why?
|
Pancreas | 1 | 2021 | 1684 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2023 | 21719 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2120 | 0.030 |
Why?
|
Models, Animal | 1 | 2020 | 2170 | 0.030 |
Why?
|
Disease Outbreaks | 1 | 2023 | 1768 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2895 | 0.030 |
Why?
|
Adiponectin | 1 | 2019 | 1099 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2019 | 1015 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2019 | 2378 | 0.030 |
Why?
|
Imidazoles | 1 | 2018 | 1205 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4211 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2020 | 1731 | 0.030 |
Why?
|
Triglycerides | 1 | 2019 | 2450 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18006 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5454 | 0.020 |
Why?
|
Autophagy | 1 | 2019 | 1301 | 0.020 |
Why?
|
Vaccination | 1 | 2023 | 3256 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7790 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5062 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3661 | 0.020 |
Why?
|
Cell Movement | 1 | 2022 | 5212 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3518 | 0.020 |
Why?
|
Myocardium | 1 | 2021 | 4775 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11363 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2022 | 16665 | 0.020 |
Why?
|
Models, Biological | 1 | 2021 | 9581 | 0.020 |
Why?
|
Cell Line | 1 | 2019 | 15994 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2023 | 77098 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15530 | 0.010 |
Why?
|
Adult | 3 | 2022 | 213712 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20928 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 29717 | 0.010 |
Why?
|
Aged | 2 | 2021 | 162944 | 0.010 |
Why?
|
Middle Aged | 2 | 2021 | 213127 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 62966 | 0.010 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(16)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_